filmov
tv
RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone
Показать описание
Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.
RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone
0:26:24
RheumNow Podcast – Jack of All Subspecialties (10.1.2021)
0:20:50
RheumNow Podcast - Unwillingness to Change Therapy
0:31:36
RheumNow PsA SpA EULAR 2021 PANEL w/Drs. Cush, Ruderman, Tate and Chao
0:15:10
RheumNow Podcast – Systemic Sclerosis Pearls (2.19.2021)
0:14:56
RheumNow Podcast – Rheumatologist Salaries (12.21.18)
0:19:00
RheumNow Podcast – As Good As I Ever Was (7.2.2021)
0:19:28
Infections & Lupus (10.28.2022)
0:39:28
Osteoarthritis Roundtable: Best from ACR 2021
0:10:42
TNF Inhibitors Rise to the Top: Drs. Janet Pope and David Liew
0:24:24
RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)
0:17:45
Male vs. Female Responders (4.15.2022)
0:23:28
RheumNow (ACR16) Week in Review – 18 November 2016
0:02:46
Lupus and Pregnancy: Dr. Sheila Reyes
0:20:24
Pain in the Neck (7.28.2023)
0:25:45
The Overpricing of Drugs (1.14.2022)
0:05:00
Rheumatology Roundup Review - Dr. Jack Cush
1:01:40
RheumNow Rheumatology Roundup
0:17:51
TNF Inhibitor Panel Discussion: ACR21 Annual Meeting
0:20:15
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie
0:33:46
AOSD - Adult-onset Still's disease
1:05:07
Tuesday Night Rheumatology: POD 7: Spondyloarthritis Innovations
0:04:14
Infliximab Drug Monitoring in PsA, RA, AxSpA: Dr. Pedro Castillo
0:11:23
Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim
Комментарии